Sign in
Not yet recruitingNo phase

Remote Ischemic Postconditioning in Septic Shock

Key facts

Who runs it
Hospices Civils de Lyon
Where
France23 sites in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
720 people, planned
Starts
Jan 2027
Expected to end
Apr 2029
Type of study
Interventional, 2 groups
Treatments tested
  • Remote ischemic conditioning
Record updated
9 October 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Age ≥ 18 years
  • Hospitalized in intensive care unit for less than 24 hours
  • Septic shock (Sepsis-3 definition) evolving for less than 18 hours
  • Preliminary written informed consent obtained from the patient or his/her close relative, or use of the emergency procedure in accordance with local regulations

Who cannot take part

  • Cardiac arrest
  • Contraindication of the use of a brachial pressure cuff on both arms
  • Pregnancy or breast feeding
  • Participation in another interventional study
  • Lack of French national health insurance coverage
  • Patient with any legal protection measure

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Septic shock is a leading cause of death worldwide despite intensive research efforts. Only a few interventions have been proven to be effective in improving patient-centered outcomes. Recent clinical trials have reported the safety and efficacy of remote ischemic postconditioning (RIPOST) in a variety of pathologies, including myocardial infarction, cardiac surgery, and stroke. While RIPOST was mainly tested in pathologies with low mortality rates, several follow-up studies of large randomized clinical trials in acute myocardial infarction and in patients undergoing coronary artery bypass surgery have reported significant decreases (> 50%) in long-term mortality. Experimental studies and proof-of-concept clinical trials have also suggested the potential benefits of RIPOST on mortality in sepsis and septic shock. The present protocol aims to test whether this non-invasive, widely available, inexpensive, and innovative intervention can improve survival in septic shock.

The 2 groups in the trial

  • Remote ischemic conditioningTreatment being tested

    A brachial cuff is positioned around one arm of the patient. Remote ischemic conditioning consists of alternating inflations and deflations of the brachial cuff. Four cycles of ischemic conditioning (5-min brachial cuff inflation at 200 mmHg followed by 5-min cuff deflation) are started as soon as possible after inclusion. The intervention is repeated 12 and 24 hours after inclusion.

  • Control groupOther group

    No intervention wil be performed in the control group.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
9 October 2026